DREAMSNCT07941466
Dose Reduced Alteplase in Managing Intrapleural Sepsis
StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Treatment Success
Timeframe: From enrollment to standard treatment follow-up within 60 days following the first dose of intrapleural enzyme therapy
Arms and interventions
Reduced Dose Alteplase IETExperimental
Alteplase 4mg with 5mg DNase twice daily for six doses
Standard Dose Alteplase IETActive comparator
Alteplase 10mg with 5mg DNase twice daily for six doses
Drugs: Reduced Dose Alteplase, Standard Dose Alteplase